生物利用度
医学
疾病
健康福利
重症监护医学
生物强化
功能性食品
药理学
疾病预防
神经保护
生物信息学
神经科学
代谢稳定性
人类健康
代谢性骨病
生物技术
心血管健康
健骨
临床实习
氧化还原
膳食补充剂
抗氧化剂
退行性疾病
同化(音韵学)
能源消耗
作者
Rongzeng Pan,Jia Zeng,Xiaojun Wang,Biyan Cui,Chuanling Deng,Xiaoguang Xu,Zhen-Yu Chen,Hanyue Zhu
标识
DOI:10.1080/10408398.2026.2676108
摘要
Orthosilicic acid (OSA), the principal bioavailable form of silicon, is emerging as a vital functional food ingredient. This review synthesizes current evidence on OSA's dietary sources, bioavailability, metabolic fate, and biological mechanisms. Given that OSA's natural bioavailability varies, stabilized delivery systems-such as choline-stabilized OSA and monomethylsilanetriol-and novel biofortification strategies are critical for optimizing its physiological benefits. Major findings indicate that OSA targets connective tissues to promote bone health by stimulating osteoblastic activity and inhibiting osteoclasts. Additionally, preclinical studies suggest that OSA has the potential to enhance collagen synthesis, support vascular repair, and exert anti-inflammatory and neuroprotective effects. Despite processing stability challenges, OSA holds significant promise. Future research should elucidate its combined roles, particularly within the proposed bone-vascular-immune axis. This review critically evaluates the bioavailability gaps and proposes the "Bone-Vascular-Immune Axis" as a novel theoretical framework for future functional food development.
科研通智能强力驱动
Strongly Powered by AbleSci AI